<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Biosimilar User Fee Act; Public Meeting</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Biosimilar User Fee Act; Public Meeting</h1>
    <p class="timestamp">Published: 2016-09-19 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing a public meeting to discuss proposed recommendations for the reauthorization of the Biosimilar User Fee Act (BsUFA) for fiscal years (FYs) 2018 through 2022. BsUFA authorizes FDA to collect fees and use them for the process for the review of biosimilar biological product applications. The current legislative authority for BsUFA expires in September 2017. At that time, new legislation will be required for FDA to continue collecting bi...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2016-22442</p>
    <p><strong>Publication Date:</strong> 2016-09-19</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2016/09/19/2016-22442/biosimilar-user-fee-act-public-meeting">https://www.federalregister.gov/documents/2016/09/19/2016-22442/biosimilar-user-fee-act-public-meeting</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2016-22442</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
